Covered recipient · General Payments record
RABIN KHERADPOUR
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$1,888.80
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $594.21 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $248.09 | 2 |
| Novo Nordisk AS | $232.66 | 8 |
| Lilly USA, LLC | $113.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $121.52 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105426594 | CMS |
| AstraZeneca Pharmaceuticals LP | $126.57 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105732831 | CMS |
| Lilly USA, LLC | $113.46 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135305708 | CMS |
| Novo Nordisk Inc | $11.04 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097577818 | CMS |
| Novo Nordisk Inc | $15.25 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097807683 | CMS |
| Novo Nordisk Inc | $16.68 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096580577 | CMS |
| Novo Nordisk Inc | $17.00 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097143254 | CMS |
| Novo Nordisk Inc | $116.15 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097225515 | CMS |
| Novo Nordisk Inc | $19.79 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096887338 | CMS |
| Novo Nordisk Inc | $15.40 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097394963 | CMS |
| Novo Nordisk Inc | $21.35 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096674901 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.